[1] SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
[2] WILLATT J M,FRANCIS I R,NOVELLI P M,et al.Interventional therapies for hepatocellular carcinoma[J].Cancer Imaging,2012,12:79-88.
[3] SU X,XING J,WANG Z,et al.MicroRNAs and ceRNAs:RNA networks in pathogenesis of cancer[J].Chin Cancer Res,2013,25(2):235-239.
[4] XU Y,HUANG J,MA L,et al.MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways[J].Cancer Lett,2016,371(2):171-181.
[5] CHEN S L,LI F,CHAI H Y,et al.The expression and clinical significance of micro RNA-122 in different chronic liver diseases with HBV infection[J].Chin J Exp Clin Infect Dis(Electronic Version),2015,9(6):68-72.
[6] KARAKATSANIS A,PAPACONSTANTINOU I,GAZOULI M,et al.Expression of miRNAs,miR-21,miR-31,miR-122,miR-145,miR-146a,miR-200c,miR-221,miR-222 and miR-223 in pations with hepatocellulao caycinoma or intrahepatic cholangiocarcinoma and its prognostic significane[J].Mol Carcniog,2013,52(4):297-303.
[7] ZHUANG P,LI Z Y,WANG P C,et al.The functional characterization of the human liver-specific miR-122expression in hepatocullar carcinoma[J].China J Immun,2013,29(7):686-688.
[8] KISHIKAWA T,OTSUKA M,TAN P S,et al.Decreased miRl22 in hepatocellular carcinoma leads to chemoresistance with increased arginine[J].Oncotarget,2015,6(10):8339-8352.
[9] JIN J C,ZHANG X,JIN X L,et al.MicroRNA-122 regulation of the morphology and cytoarehitecture of hepatoma carcinoma cells[J].Mol Med Rep,2014,9(4):1376-1380.
[10] JIN J C,ZHANG X,JIN X L,et al.MicroRNA-122 regulation of the morphology and ytoarchitecture of hepatoma carcinoma cells[J].Mol Med Rep,2014,9(4):1376-1380.
[11] WAIDMANN O,BIHRER V,PLELI T,et al.Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virusinfection[J].J Viral Hepat,2012,19(2):58-65.
[12] KUTAY H,BAI S,DATTA J,et al.Downregulation of miR-122 in the rodent and human hepatocellular carcinomas[J].J Cell Biochem,2006,99(3):671-678.
[13] GRAMANTIERI L,FERRACIN M,FOMARI F,et al.Cyclin G1 is a target of miR-l 22.a microRNA frequently down-regulated in human hepatocellular carcinoma[J].Cancer Res,2007,67(13):6092-6099.
[14] NAKAO K,MIYAAKI H,ICHIKAWA T.Antitumor function of microRNA-122 against hepatocellular carcinoma[J].J Gastroenterol,2014,49(4):589-593.
[15] XU Y,BU X,DAI C,et al.High serum microRNA-122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients[J].Tumour Biol,2015,36(6):4773-4776.
[16] 杨颖卓,康鹏,高杰,等.肝特异性miR-122调控肝脏疾病的研究进展[J].临床肝胆病杂志,2014,30(5):473-477.
[17] 张迎建,李文超,杨红.microRNA+在预防医学中的研究进展[J].东南大学学报:医学版,2013,32(5):606-611.
[18] 韩力,刘琳.靶向VEGF/VEGFR路径治疗肝细胞癌的临床研究进展[J].东南大学学报:医学版,2017,36(2):240-244. |